Maravai LifeSciences
(NASDAQ:MRVI)
$10.46
0[0.00%]
At close: May 13
$10.46
0[0.00%]
PreMarket: 4:34AM EDT
Q1 2024 Earnings were released on Wed May 8th, after the market close
The most recent conference call was at 17:00 PM, 5 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Maravai LifeSciences Stock (NASDAQ:MRVI), Quotes and News Summary

Maravai LifeSciences Stock (NASDAQ: MRVI) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.129.000 / 2.820M
Day Range- - -
52 Wk Range4.520 - 16.620
Market Cap$1.389B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
78
Short Interest
5.77%
Days to Cover2.7

Recent News

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.
Avi Kapoor
Nasdaq Edges Lower; AXT Shares Surge After Q4 Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.2% on Friday. The Dow traded up 0.23% to 39,158.52 while the NASDAQ fell 0.19% to 16,011.27. The S&P 500 also rose, gaining, 0.11% to 5,092.83.   Leading and Lagging Sectors  
Avi Kapoor
Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance
Maravai LifeSciences impresses with Q4 2023 revenue of $74.1 million, surpassing estimates. CEO Trey Martin highlights strong execution, cost reductions, and a 28% adjusted EBITDA margin. 2024 revenue guidance of $265-$285 million exceeds expectations.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
2
Feb
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MRVI
MEDP

FAQ

Q

How do I buy Maravai LifeSciences (MRVI) stock?

A

You can purchase shares of Maravai LifeSciences (NASDAQ: MRVI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Maravai LifeSciences's (MRVI) competitors?

A

Other companies in Maravai LifeSciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Sotera Health (NASDAQ:SHC).

Q

What is the target price for Maravai LifeSciences (MRVI) stock?

A

The latest price target for Maravai LifeSciences (NASDAQ: MRVI) was reported by Baird on Thursday, May 9, 2024. The analyst firm set a price target for 10.00 expecting MRVI to fall to within 12 months (a possible -4.40% downside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Maravai LifeSciences (MRVI)?

A

The stock price for Maravai LifeSciences (NASDAQ: MRVI) is $10.46 last updated Today at May 13, 2024 at 4:34 AM EDT.

Q

Does Maravai LifeSciences (MRVI) pay a dividend?

A

There are no upcoming dividends for Maravai LifeSciences.

Q

When is Maravai LifeSciences (NASDAQ:MRVI) reporting earnings?

A

Maravai LifeSciences’s Q2 earnings are confirmed for Monday, August 5, 2024.

Q

Is Maravai LifeSciences (MRVI) going to split?

A

There is no upcoming split for Maravai LifeSciences.

Q

What sector and industry does Maravai LifeSciences (MRVI) operate in?

A

Maravai LifeSciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch